BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10748299)

  • 1. 17p- syndrome arising from a novel dicentric translocation in a patient with acute myeloid leukemia.
    Watson N; Dunlop L; Robson L; Sharma P; Smith A
    Cancer Genet Cytogenet; 2000 Apr; 118(2):159-62. PubMed ID: 10748299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new nonrandom unbalanced t(17;20) in myeloid malignancies.
    Patsouris C; Michael PM; Campbell LJ
    Cancer Genet Cytogenet; 2002 Oct; 138(1):32-7. PubMed ID: 12419582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG).
    Jaju RJ; Haas OA; Neat M; Harbott J; Saha V; Boultwood J; Brown JM; Pirc-Danoewinata H; Krings BW; Müller U; Morris SW; Wainscoat JS; Kearney L
    Blood; 1999 Jul; 94(2):773-80. PubMed ID: 10397745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ.
    Soenen V; Preudhomme C; Roumier C; Daudignon A; Laï JL; Fenaux P
    Blood; 1998 Feb; 91(3):1008-15. PubMed ID: 9446663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A FISH comparison of variant derivatives of the recurrent dic(17;20) of myelodysplastic syndromes and acute myeloid leukemia: Obligatory retention of genes on 17p and 20q may explain the formation of dicentric chromosomes.
    MacKinnon RN; Patsouris C; Chudoba I; Campbell LJ
    Genes Chromosomes Cancer; 2007 Jan; 46(1):27-36. PubMed ID: 17048234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Huët anomaly and small vacuolated granulocytes.
    Laï JL; Zandecki M; Fenaux P; Le Baron F; Bauters F; Cosson A; Deminatti M
    Cancer Genet Cytogenet; 1990 Jun; 46(2):173-83. PubMed ID: 2340488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
    Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
    Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unbalanced translocation der(5;17) resulting in a TP53 loss as recurrent aberration in myelodysplastic syndrome and acute myeloid leukemia with complex karyotype.
    Warnstorf D; Bawadi R; Schienke A; Strasser R; Schmidt G; Illig T; Tauscher M; Thol F; Heuser M; Steinemann D; Davenport C; Schlegelberger B; Behrens YL; Göhring G
    Genes Chromosomes Cancer; 2021 Jun; 60(6):452-457. PubMed ID: 33486841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New complex t(2;11;17)(p21;q23;q11), a variant form of t(2;11), associated with del(5)(q23q32) in myelodysplastic syndrome-derived acute myeloblastic leukemia.
    Yamamoto K; Nagata K; Morita Y; Inagaki K; Hamaguchi H
    Cancer Genet Cytogenet; 2002 Sep; 137(2):119-23. PubMed ID: 12393282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.
    Hong M; Hao S; Patel KP; Kantarjian HM; Garcia-Manero G; Yin CC; Medeiros LJ; Lin P; Lu X
    Cancer Genet; 2016 May; 209(5):205-14. PubMed ID: 27134073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-B acute lymphoblastic leukemia in a 3-year-old boy with pre-acute myelogenous leukemia myelodysplastic syndrome: cytogenetic evidence of common early progenitor cell ontogeny.
    Rossbach HC; Sutcliffe MJ; Chamizo W; Haag MM; Grana NH; Washington KR; Barbosa JL
    J Pediatr Hematol Oncol; 1998; 20(4):347-52. PubMed ID: 9703011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistent t(8;21)(q22;q22) Translocation and 5q Deletion in Acute Myeloid Leukemia.
    Yamamoto K; Yakushijin K; Sanada Y; Kawamoto S; Matsuoka H; Minami H
    J Clin Exp Hematop; 2015; 55(3):181-5. PubMed ID: 26763368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
    Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality.
    Sankar M; Tanaka K; Kumaravel TS; Arif M; Shintani T; Yagi S; Kyo T; Dohy H; Kamada N
    Leukemia; 1998 Apr; 12(4):510-6. PubMed ID: 9557609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
    Kanagal-Shamanna R; Yin CC; Miranda RN; Bueso-Ramos CE; Wang XI; Muddasani R; Medeiros LJ; Lu G
    Cancer Genet; 2013; 206(1-2):42-6. PubMed ID: 23357231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Sweet Syndrome in patients with acute myeloid leukemia.
    Kazmi SM; Pemmaraju N; Patel KP; Cohen PR; Daver N; Tran KM; Ravandi F; Duvic M; Garcia-Manero G; Pierce S; Nazha A; Borthakur G; Kantarjian H; Cortes J
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):358-363. PubMed ID: 25630528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.